Related Experiment Video
Updated: Jun 30, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Getting the most from available antiretroviral therapies
Summary
Highly active antiretroviral therapy (HAART) has transformed HIV treatment. However, the current pipeline for new HIV drugs is limited, with some promising candidates facing setbacks.
Area of Science:
- Infectious Diseases
- Virology
- Pharmacology
Background:
- Combination Highly Active Antiretroviral Therapy (HAART) has significantly reduced HIV-related morbidity and mortality over the past two decades.
- 2007 marked the introduction of novel anti-HIV drug classes: CCR5 antagonists and integrase inhibitors, expanding therapeutic options for experienced patients.
Discussion:
- Despite advancements, the current pipeline for new HIV therapeutics is notably sparse, with no major breakthroughs anticipated soon.
- The development of novel antiviral agents faces challenges, as exemplified by setbacks in clinical trials.
Key Insights:
- New drug classes approved in 2007 offer alternative treatment strategies for individuals with treatment-experienced HIV.
- The limited number of upcoming HIV drugs highlights a potential future challenge in managing the infection.
Outlook:
- The HIV maturation inhibitor bevirimat is progressing through clinical trials, representing a potential new therapeutic avenue.
- Koronis Pharmaceuticals' KP-1461, a novel mechanism agent, was halted due to insufficient antiviral activity in laboratory tests, underscoring development hurdles.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...